Aidan Bailey
About Aidan Bailey
Aidan Bailey is a Senior Research Associate at Fulcrum Therapeutics, specializing in viral vector technology and gene therapy for neuromuscular diseases. He holds a Bachelor of Science in Physics from Boston College and a Master of Science in Biomedical Engineering from Duke University.
Work at Fulcrum
Aidan Bailey currently serves as a Senior Research Associate at Fulcrum Therapeutics, a position he has held since 2021. In this role, he focuses on advancing research in gene therapy, particularly for neuromuscular diseases. His work involves utilizing advanced techniques such as PCR, fluorescent microscopy, and immunofluorescence assays. These skills contribute to the development of potential cures for conditions like Duchenne Muscular Dystrophy (DMD) and Amyotrophic Lateral Sclerosis (ALS).
Education and Expertise
Aidan Bailey earned a Bachelor of Science in Physics from Boston College, studying from 2015 to 2019. He furthered his education at Duke University, obtaining a Master of Science in Biomedical/Medical Engineering from 2019 to 2020. His academic background provides a strong foundation for his extensive expertise in viral vector technology and gene therapy efficacy, particularly in the context of neuromuscular diseases.
Background
Before his current role at Fulcrum Therapeutics, Aidan Bailey gained valuable research experience as an Undergraduate Research Fellow at Boston College from 2017 to 2019. He then worked as a Graduate Student Researcher at Duke University School of Medicine from 2019 to 2020. These positions allowed him to develop advanced skills in molecular cloning and histology, which are critical to his current research efforts.
Research Skills and Techniques
Aidan Bailey possesses advanced research skills that enhance his contributions to the field of gene therapy. His expertise includes molecular cloning, histology, PCR, and image analysis. He employs these techniques in his research to investigate muscle biology and develop therapies for neuromuscular diseases. His proficiency in fluorescent microscopy and immunofluorescence assays supports his work in advancing potential treatments.